Magnetic Resonance Imaging of the Axial Skeleton for Detecting Bone Metastases in Patients With High-Risk Prostate Cancer: Diagnostic and Cost-Effectiveness and Comparison With Current Detection Strategies
- 1 August 2007
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (22), 3281-3287
- https://doi.org/10.1200/jco.2006.09.2940
Abstract
Purpose To evaluate the diagnostic performance, costs, and impact on therapy of one-step magnetic resonance imaging (MRI) of the axial skeleton (MRIas) for detecting bone metastases in patients with high-risk prostate cancer (PCa). Patients and Methods Sixty-six consecutive patients with high-risk PCa prospectively underwent MRIas in addition to the standard sequential work-up (SW) of bone metastases (technetium-99m bone scintigraphy [BS] completed with targeted x-rays [TXR] in patients with equivocal BS findings and with MRI obtained on request [MRIor] in patients with inconclusive BS/TXR findings). Panel review of initial and 6-month follow-up MRI findings, BS/TXR, and all available baseline and follow-up clinical and biologic data were used as the best valuable comparator to define metastatic status. Diagnostic effectiveness of MRIas alone was compared with each step of the SW. Impact of MRIas screening on patient management and costs was evaluated. Results On the basis of the best valuable comparator, 41 patients (62%) had bone metastases. Sensitivities were 46% for BS alone, 63% for BS/TXR, 83% for BS/TXR/MRIor, and 100% for MRIas; the corresponding specificities were 32%, 64%, 100%, and 88%, respectively. MRIas was significantly more sensitive than any other approach (P < .05, McNemar). MRIas identified metastases in seven (30%) of 23 patients considered negative and eight (47%) of 17 patients considered equivocal by other strategies, which altered the initially planned therapy. Economic impact was variable among countries, depending on reimbursement rates. Conclusion MRIas is more sensitive than the current SW of radiographically identified bone metastases in high-risk PCa patients, which impacts the clinical management of a significant proportion of patients.Keywords
This publication has 40 references indexed in Scilit:
- Value of Whole-Body Turbo Short Tau Inversion Recovery Magnetic Resonance Imaging With Panoramic Table For Detecting Bone MetastasesJournal of Computer Assisted Tomography, 2006
- Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastasesThe Prostate, 2005
- Whole Body MRI for Detecting Metastatic Bone Tumor: Comparison with Bone ScintigramsMagnetic Resonance in Medical Sciences, 2005
- Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancerEuropean Radiology, 2003
- Prognostic Value of Bone Scan in Patients With Metastatic Prostate Cancer Treated Initially With Androgen Deprivation TherapyJournal of Urology, 2002
- Early Detection and Accurate Description of Extent of Metastatic Bone Disease in Breast Cancer With Fluoride Ion and Positron Emission TomographyJournal of Clinical Oncology, 1999
- Bone scanning in clinical oncology: does it have a future?European Journal of Nuclear Medicine and Molecular Imaging, 1998
- Magnetic resonance imaging of the bone marrow in hematological malignanciesEuropean Radiology, 1998
- Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scanCancer, 1988
- MRI in the detection of malignant infiltration of bone marrowAmerican Journal of Roentgenology, 1986